美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

SPDR S&P Biotech ETF

151.40

-2.3700-1.54%

盘后：151.500.1000+0.07%17:18 EDT

成交量：604.47万

成交额：9.19亿

市值：101.10亿

市盈率：8.30

高：154.12

开：153.43

低：151.10

收：153.77

52周最高：169.89

52周最低：103.43

股本：6,677.50万

流通股本：6,677.50万

量比：0.51

换手率：9.05%

股息：0.54

股息率：0.36%

每股收益(TTM):18.23

净资产收益率：--

总资产收益率：--

市净率：--

市盈率(LYR):- -

数据加载中...

总览公司新闻资讯公告

ADP报告：自5月以来，招聘活动首次加速，其中教育、医疗保健以及休闲和酒店行业引领增长。金融活动以及专业和商业服务行业则

共享基经丨14只生物科技ETF怎么选？港股、A股赛道有何不同？

每日经济新闻

蓝丰生化投资成立生物科技公司

伯恩斯坦列出中国生物医药重点标的：药明康德、信达生物、恒瑞医药、翰森制药

Ourea Biotech HK Limited减持劲方医药-B(02595)600万股每股作价27.3港元

科技部：“十五五”时期将加强人工智能、量子科技、生物科技、脑机接口等前沿技术的研发

宜明昂科-B(01541)附属宜明凯尔生物医药技术(上海)完成增资

绿地全国8城OPC智能体社区同步揭牌，北京项目落子大兴生物医药基地

国家医保局局长章轲会见印度尼西亚国家健康保险首席执行官普约瓦斯基托

模型公司入局生物医药：2026，AI制药迎来关键之年

【律师讲堂】秦天说法 | “超龄用工≠随便用工”，速看，超龄劳动者权益保障新规怎么说！

纳指时隔近4个月再创新高背后：“七巨头”退潮，生物科技、AI智能体接棒，美股10月面临三重考验

每日经济新闻

港股收评：三大指数齐跌！新能源车企、石油走弱，生物医药逆势上扬

港股生物医药概念股走高，金斯瑞生物科技涨超9%

每日经济新闻

港股生物医药概念走高，金斯瑞生物科技涨超9%

港股异动 | CRO概念股涨幅居前花旗指美对华药企授权政策前景偏正面继续看好创新药及生物科技

夏邑人速看!延续实施扩大社会保险补贴范围政策，直补个人，最长可领12个月!

兰州市自明年起不再向用人单位收取退休人员大额医疗保险费

中国兰州网

医疗保健行业综述：市场观察

实施强省会战略系列报道丨锚定万亿目标主导产业加快聚势跃升

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hans/stock/XBI/news?page=3"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"XBI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBI\",,,,,undefined,":{"symbol":"XBI","market":"US","secType":"STK","nameCN":"SPDR S&P Biotech ETF","latestPrice":151.4,"timestamp":1791835200000,"preClose":153.77,"halted":0,"volume":6044732,"hourTrading":{"tag":"盘后","latestPrice":151.5,"preClose":151.4,"latestTime":"17:18 EDT","volume":3470,"amount":524571.8021,"timestamp":1791839905964,"change":0.1,"changeRate":0.000661,"amplitude":0.002774},"delay":0,"changeRate":-0.015412629251479511,"floatShares":66775000,"shares":66775000,"eps":18.23,"marketStatus":"盘后交易","change":-2.37,"latestTime":"10-12 17:18:32 EDT","open":153.43,"high":154.12,"low":151.1,"amount":919275951.5655199,"amplitude":0.01964,"askPrice":151.7,"askSize":500,"bidPrice":151.21,"bidSize":200,"shortable":3,"etf":1,"ttmEps":18.23,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1791849600000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":153.77,"sharesOutstanding":63325000,"nav":153.722719,"aum":10430086474.925,"dividendRate":0.003555,"bidAskSpread":0.000294,"preHourTrading":{"tag":"盘前","latestPrice":153.9,"preClose":153.77,"latestTime":"09:26 EDT","volume":6687,"amount":1030664.76894,"timestamp":1791811594916,"change":0.13,"changeRate":0.000845,"amplitude":0.00676},"postHourTrading":{"tag":"盘后","latestPrice":151.5,"preClose":151.4,"latestTime":"17:18 EDT","volume":3470,"amount":524571.8021,"timestamp":1791839905964,"change":0.1,"changeRate":0.000661,"amplitude":0.002774},"volumeRatio":0.513911,"impliedVol":0.3238,"impliedVolPercentile":0.6574},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBI\",,,,,undefined,":{"symbol":"XBI","floatShares":66775000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.513911,"shares":66775000,"dividePrice":0.5382,"high":154.12,"amplitude":0.01964,"preClose":153.77,"low":151.1,"week52Low":103.43,"pbRate":"--","week52High":169.89,"institutionHeld":0.8511,"latestPrice":151.4,"committee":-0.428571,"eps":18.23,"divideRate":0.003555,"volume":6044732,"delay":0,"ttmEps":18.23,"open":153.43,"prevYearClose":121.93,"prevWeekClose":153.77,"prevMonthClose":157.68,"prevQuarterClose":157.68,"fiveDayClose":156.19,"twentyDayClose":157.6,"sixtyDayClose":154.26},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/XBI\",params:#limit:5,,,undefined,":[{"date":"2026-06-22","symbol":"XBI","amount":0.138094,"announcedDate":"2026-06-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-24","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-24"},{"date":"2025-12-22","symbol":"XBI","amount":0.406564,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-24"},{"date":"2025-09-22","symbol":"XBI","amount":0.02665,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-24","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-24"},{"date":"2025-06-23","symbol":"XBI","amount":0.007295,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-25","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-25"},{"date":"2025-03-24","symbol":"XBI","amount":0.00525,"announcedDate":"2025-03-21","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-24","defaultRemindTime":1742823000000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-26","payableDate":"2025-03-24","currency":"USD","dateTimestamp":1742788800000,"payDate":"2025-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"XBI\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-27","value":0.01831,"currency":"USD"},{"executeDate":"2017-03-17","recordDate":"2017-03-21","paymentDate":"2017-03-27","value":0.019702,"currency":"USD"},{"executeDate":"2017-06-16","recordDate":"2017-06-20","paymentDate":"2017-06-26","value":0.110135,"currency":"USD"},{"executeDate":"2017-09-15","recordDate":"2017-09-18","paymentDate":"2017-09-25","value":0.03704,"currency":"USD"},{"executeDate":"2018-03-16","recordDate":"2018-03-19","paymentDate":"2018-03-21","value":0.059081,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"XBI\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"XBI\",pageSize:20,pageCount:3,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2671361204","title":"ADP报告：自5月以来，招聘活动首次加速，其中教育、医疗保健以及休闲和酒店行业引领增长。金融活动以及专业和商业服务行业则","url":"https://stock-news.laohu8.com/highlight/detail?id=2671361204","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671361204?lang=zh_cn&edition=fundamental","pubTime":"2026-09-30 20:21","pubTimestamp":1790770861,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4550","CGVV","PEJ","NOBL","BK4581","LABU","BK4588","VHT","XLV","BK4585","159940","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671208951","title":"共享基经丨14只生物科技ETF怎么选？港股、A股赛道有何不同？","url":"https://stock-news.laohu8.com/highlight/detail?id=2671208951","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671208951?lang=zh_cn&edition=fundamental","pubTime":"2026-09-30 17:51","pubTimestamp":1790761879,"startTime":"0","endTime":"0","summary":"9月30日，A股主要指数走势分化，上证指数收涨0.31%，深证成指、创业板指小幅收跌。盘面上，医药生物板块表现突出，CRO、重组蛋白、疫苗、细胞免疫治疗等细分赛道涨幅居前。港股方面，恒生指数小幅上涨，港股生物技术、CXO板块成为市场主线。从ETF来看，疫苗、生物科技、港股创新药、医疗主题相关ETF涨幅居前。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://stock.eastmoney.com/a/202609303887797810.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.eastmoney.com/a/202609303887797810.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02827","BK4585","02823","SYNB","BK4581","82823","83188","03188","07233","XBI","82822","399300","BK1610","LNGR","02822","GDOC","03130","IBBJ","MEDX","BK4588","83130","FDN","02843","82843","IEIH","02846","82846","159982","BK4550","KCAI","BK1147","AGNG","159837","VXUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671327280","title":"蓝丰生化投资成立生物科技公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2671327280","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671327280?lang=zh_cn&edition=fundamental","pubTime":"2026-09-30 16:45","pubTimestamp":1790757955,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IEIH","AGNG","IBBJ","BK4585","GDOC","MEDX","BK4581","LNGR","XBI","SYNB","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671427661","title":"伯恩斯坦列出中国生物医药重点标的：药明康德、信达生物、恒瑞医药、翰森制药","url":"https://stock-news.laohu8.com/highlight/detail?id=2671427661","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671427661?lang=zh_cn&edition=fundamental","pubTime":"2026-09-30 15:14","pubTimestamp":1790752445,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4585","BK4588","XBI","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671747216","title":"Ourea Biotech HK Limited减持劲方医药-B(02595)600万股 每股作价27.3港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2671747216","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671747216?lang=zh_cn&edition=fundamental","pubTime":"2026-09-29 19:15","pubTimestamp":1790680502,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新数据显示，9月24日，Ourea Biotech HK Limited减持劲方医药-B600万股，每股作价27.3港元，总金额为1.638亿港元。减持后最新持股数目约为1630.69万股，最新持股比例为4.64%。本交易涉及其他关联方：HL GP II Company Limited、HL Partners II L.P.补充资料：Ourea Biotech由HL Partners II L.P.控制，而HL Partners II L.P.是一家根据开曼群岛法律成立的有限合伙企业，最终由其普通合伙人HL GP II Company Limited管理。因此，根据证券及期货条例，HL Partners II L.P.及HL GP II Company Limited各自被视为于Ourea Biotech所持股份中拥有权益。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1502210.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","EWH","02595","BK4588","BK1161","BK1515","BK4581","BK4585","XBI","159938","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671294694","title":"科技部：“十五五”时期将加强人工智能、量子科技、生物科技、脑机接口等前沿技术的研发","url":"https://stock-news.laohu8.com/highlight/detail?id=2671294694","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671294694?lang=zh_cn&edition=fundamental","pubTime":"2026-09-29 16:03","pubTimestamp":1790669028,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["AIQU","KOMP","CPNQ","GDOC","QQQX","PBOT","AGNG","TQQQ","QID","QQQM","AIFD","AGIX","QSWN","LNGR","VUSE","NBDS","QUA","AIBU","159837","NOCT","QTOC","QQQ","ARTY","LCLG","AQGX","SYNB","QTUP","MVPS","QQA","MEDX","TARK","GPIQ","IBBJ","GK","IBRN","XBI","MFIG","TECY","161631","FWD","DQJN","QBTZ","NEWZ","MNTL","CWC","OGIG","CHAT","WPAI","IEIH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670255434","title":"宜明昂科-B(01541)附属宜明凯尔生物医药技术(上海)完成增资","url":"https://stock-news.laohu8.com/highlight/detail?id=2670255434","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670255434?lang=zh_cn&edition=fundamental","pubTime":"2026-09-28 22:40","pubTimestamp":1790606412,"startTime":"0","endTime":"0","summary":"智通财经APP讯，宜明昂科-B(01541)发布公告，内容有关附属宜明凯尔生物医药技术(上海)获增资5000万元。于本公告日期，增资及有关增资的相关工商登记程序已完成。投资者已根据增资协议完成支付人民币5000万元的对价。增资完成后，目标公司宜明凯尔生物医药技术(上海)有限公司分别由公司、嘉兴昶新、生科起航、新界创元及王先生持有约68.34%、15.83%、6.33%、6.33%及3.17%股权。因此，目标公司仍为公司非全资附属公司，且其财务业绩继续并入集团财务报表。目标公司主要从事开发代谢性疾病及罕见病创新药物。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1501759.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","BK4581","BK4585","161726","399441","01541","BK1161","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670362922","title":"绿地全国8城OPC智能体社区同步揭牌，北京项目落子大兴生物医药基地","url":"https://stock-news.laohu8.com/highlight/detail?id=2670362922","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670362922?lang=zh_cn&edition=fundamental","pubTime":"2026-09-28 18:21","pubTimestamp":1790590860,"startTime":"0","endTime":"0","summary":"作为绿地集团全国布局的重要支点，北京大兴智汇健康城·绿地OPC社区当天在大兴生物医药基地举行揭牌仪式。此次8城同步揭牌，标志着绿地全国OPC社区布局进入规模化落地阶段，北京大兴智汇健康城是这一布局在京津冀区域的首个落地成果，将打造大兴生物医药基地首个聚焦AI与医疗健康交叉领域的OPC创业载体。随着红绸落下，社区正式启动运营，绿地全国8城OPC智能体社区同步揭牌。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-09-28/doc-initkpfc9767482.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["161726","BK4588","BK4585","399441","BK4581","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670288191","title":"国家医保局局长章轲会见印度尼西亚国家健康保险首席执行官普约瓦斯基托","url":"https://stock-news.laohu8.com/highlight/detail?id=2670288191","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670288191?lang=zh_cn&edition=fundamental","pubTime":"2026-09-28 10:52","pubTimestamp":1790563959,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4588","XLV","XBI","BK4585","LABU","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670402915","title":"模型公司入局生物医药：2026，AI制药迎来关键之年","url":"https://stock-news.laohu8.com/highlight/detail?id=2670402915","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670402915?lang=zh_cn&edition=fundamental","pubTime":"2026-09-28 07:28","pubTimestamp":1790551680,"startTime":"0","endTime":"0","summary":"伴随AI技术的快速迭代，AI制药似乎迎来了新的转机。科技巨头加快布局掌握高水平通用模型的头部AI模型公司在今年加强了在生物医药方面的布局。在生物医药研发的各个环节中，如何将AI筛选和设计的药物分子更高效地在实验室中进行验证，是AI应用的一大难题。模型公司入局生物医药，“推进干湿闭环，让模型‘长’出实体，可能会是行业颠覆。”","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2026-09-28/doc-initirzr3976058.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-09-28/doc-initirzr3976058.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4588","CHAT","BK4585","QTOC","BK1574","399441","VTHR","XBI","BK1191","161726","BK4581","AGIX","AIPO","01477","ARTY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670475113","title":"【律师讲堂】秦天说法 | “超龄用工≠随便用工”，速看，超龄劳动者权益保障新规怎么说！","url":"https://stock-news.laohu8.com/highlight/detail?id=2670475113","media":"天津东丽","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670475113?lang=zh_cn&edition=fundamental","pubTime":"2026-09-26 14:30","pubTimestamp":1790404200,"startTime":"0","endTime":"0","summary":"用人单位应当保障超龄劳动者获得劳动报酬、休息休假、劳动安全卫生、工伤保障等基本权益。双方约定的终止条件出现或者双方协商一致解除用工协议的，用工终止。超龄劳动者因工作原因受到事故伤害或者患职业病的，按照规定进行工伤认定、劳动能力鉴定并享受相应的工伤保障待遇。超龄劳动者工伤保障办法另行制定。第二十二条工会依法维护超龄劳动者的合法权益，对用人单位保障超龄劳动者的合法权益情况进行监督。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/wm/2026-09-26/doc-initcuta8573876.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LABU","BK4585","XLV","BK4581","XBI","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670947324","title":"纳指时隔近4个月再创新高背后：“七巨头”退潮，生物科技、AI智能体接棒，美股10月面临三重考验","url":"https://stock-news.laohu8.com/highlight/detail?id=2670947324","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670947324?lang=zh_cn&edition=fundamental","pubTime":"2026-09-26 12:28","pubTimestamp":1790396899,"startTime":"0","endTime":"0","summary":"在经历近4个月震荡、一度回撤超过10%后，周二（9月22日）纳斯达克综合指数重新突破6月初高点，再创新高。本周，纳斯达克综合指数累计上涨2.06%（546.17点），周收盘点位也创下新高。这V型反弹背后，美股悄然洗牌，告别了此前由“七巨头”和半导体主导的单一上涨格局。生物科技板块大涨近22%成为最受资金追捧的赛道。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609263884384763.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609263884384763.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["QQQM","03086","FTEC","MEDX","SQQQ","TQQY","159659","TECL","GDOC","NQmain","PSQ","NVDA","QDEC","LNGR","XMAG","NVIW.SI","META","QQQ","QQQA","IYW","QQQX","XBI","QQQE","GPIQ","TQQQ","QQQI","TSLA","QID","07266","IEIH","JEPQ","NDX","QQQJ","MNQmain",".IXIC","159837","ONEQ","159819","AGNG","QQQY","QDTE","SYNB","GOOG","TECS","IBBJ","AAPL","QYLG","QLD","MSFT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670467794","title":"港股收评：三大指数齐跌！新能源车企、石油走弱，生物医药逆势上扬","url":"https://stock-news.laohu8.com/highlight/detail?id=2670467794","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670467794?lang=zh_cn&edition=fundamental","pubTime":"2026-09-25 16:40","pubTimestamp":1790325622,"startTime":"0","endTime":"0","summary":"恒生指数跌1.01%","market":"us","thumbnail":"https://img3.gelonghui.com/442f4-225f5f62-62e8-4a54-8c80-004f29e3b51c.png?guru_height=540&guru_width=375","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/442f4-225f5f62-62e8-4a54-8c80-004f29e3b51c.png?guru_height=540&guru_width=375"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/6809667","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["159019","OIH","DIG","399941","USL","DBC","XLE","BK4585","159875","KCAI","USE","USOI","IEO","OILK","DRIP","IXC","GUSH","OILU","PXJ","OILT","VXUS","WTIU","VDE","160640","DBE","399441","FTXN","BK4581","161726","XBI","XES","BK4570","BK4588","PXE","000941.SH","XOP","BNO","ERX","DRLL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670544393","title":"港股生物医药概念股走高，金斯瑞生物科技涨超9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2670544393","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670544393?lang=zh_cn&edition=fundamental","pubTime":"2026-09-25 14:23","pubTimestamp":1790317403,"startTime":"0","endTime":"0","summary":"港股生物医药概念股走高，金斯瑞生物科技涨超9%","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609253884270486.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609253884270486.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["HK0000320264.USD","399441","161726","BK4588","HK0000306685.HKD","VXUS","HK0000306701.USD","KCAI","BK4585","XBI","BK1583","HK0000320223.HKD","BK1576","01548","BK4581","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670484674","title":"港股生物医药概念走高，金斯瑞生物科技涨超9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2670484674","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670484674?lang=zh_cn&edition=fundamental","pubTime":"2026-09-25 14:10","pubTimestamp":1790316645,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["VXUS","XBI","BK4581","BK4585","BK4588","KCAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670448333","title":"港股异动 | CRO概念股涨幅居前 花旗指美对华药企授权政策前景偏正面 继续看好创新药及生物科技","url":"https://stock-news.laohu8.com/highlight/detail?id=2670448333","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670448333?lang=zh_cn&edition=fundamental","pubTime":"2026-09-25 13:50","pubTimestamp":1790315418,"startTime":"0","endTime":"0","summary":"与美国国会部分议员此前主张的广泛限制不同，正在讨论的方案可能重点限制病原体以及可能被武器化的生物技术。花旗发表发布研报称，该行于24日再举办专家电话会议，讨论涉及中国公司的医药授权安排的美国政策前景，认为美国对源自中国的医药授权政策展望偏正面，并对创新药及生物科技持建设性看法。野村则表示，中国医药“十五五”规划突出创新与全球化，利好创新药企及CRDMO。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1500889.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["GDOC","XBI","LU0072461881.USD","LU1267930227.SGD","01548","IEIH","LU0029874905.USD","IBBJ","02359","AGNG","LU0456846285.SGD","SYNB","06978","LU0979878070.USD","LU0051755006.USD","LU2360032135.SGD","03347","IBBQ","LU0181495838.USD","TFNS","LNGR","HK0000320223.HKD","159992","HBImain","LU0128522744.USD","159837","LU0477156953.USD","LU1880383366.USD","LU0980610538.SGD","LU0307460666.USD","LU0516423174.USD","02269","KCAI","LU0348825331.USD","LU2125910500.SGD","BK4585","LU2456880835.USD","BK4588","LU1794554557.SGD","FTXO","LU1366192091.USD","06821","BK4559","LU0052750758.USD","KURE","VXUS","BK4504","IYF","LU0516422366.SGD","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670178448","title":"夏邑人速看!延续实施扩大社会保险补贴范围政策，直补个人，最长可领12个月!","url":"https://stock-news.laohu8.com/highlight/detail?id=2670178448","media":"掌握夏邑","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670178448?lang=zh_cn&edition=fundamental","pubTime":"2026-09-25 13:48","pubTimestamp":1790315280,"startTime":"0","endTime":"0","summary":"4.无合同年限限制:本次政策不强制要求一年以上劳动合同。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/wm/2026-09-25/doc-iniszmnc4546647.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LABU","XLV","BK4585","XBI","BK4588","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670941456","title":"兰州市自明年起不再向用人单位收取退休人员大额医疗保险费","url":"https://stock-news.laohu8.com/highlight/detail?id=2670941456","media":"中国兰州网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670941456?lang=zh_cn&edition=fundamental","pubTime":"2026-09-25 09:41","pubTimestamp":1790300460,"startTime":"0","endTime":"0","summary":"记者9月24日从兰州市医保局获悉，自2027年1月1日起，全市企业退休人员大额医疗保险费单位缴费部分不再收取，个人缴费费率及缴费方式不变；灵活就业退休人员大额医疗保险个人缴费费率减半。用人单位特别是小微企业，不再缴纳退休人员大额医疗保险费，减轻用工成本，持续优化营商环境。灵活就业退休人员大额医疗保险个人缴费费率由0.5%调整为0.25%，全年人均减轻缴费负担226.32元，有效减轻参保群众经济负担。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/wm/2026-09-25/doc-inisyywi4652149.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4585","XLV","LABU","BK4588","BK4581","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136752222","title":"医疗保健行业综述：市场观察","url":"https://stock-news.laohu8.com/highlight/detail?id=1136752222","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136752222?lang=zh_cn&edition=fundamental","pubTime":"2026-09-25 00:27","pubTimestamp":1790267220,"startTime":"0","endTime":"0","summary":"医疗保健板块最新市场观察汇总。分析师在一份研究报告中称，UCB高管在美国银行的一场活动上显得很有信心，认为公司最畅销产品Bimzelx能够抵御新药的竞争。联昌国际证券分析师Chun Sung Oong在一份报告中表示，马来西亚医疗保健板块可能继续受到非传染性疾病患病率上升、人口老龄化和健康意识增强的支撑。由于公立医院入住率高企，患者转向私立医院，IHH的业务预计将从中受益。联昌国际维持对马来西亚医疗保健板块的增持评级。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B7SZLL34.SGD","LU0234570918.USD","LU1880398471.USD","LU0130518102.USD","LU1496350502.SGD","IE0034235188.USD","LU1201861249.SGD","LU1668664300.SGD","LU1363072403.SGD","LU2265009873.SGD","LU0130517989.USD","LU0787776722.HKD","LU2129689431.USD","LU0320765646.SGD","LU1074936037.SGD","IYF","IE00BFXG1179.USD","IE00BKVL7J92.USD","LU1280957306.USD","LU0106831901.USD","LU1894683348.USD","LU0170899867.USD","LU1035773651.USD","TCAF","LU0211331839.USD","LU1894683264.USD","LU0648001328.SGD","LU0098860793.USD","XBI","LU0314106906.USD","KBWB","LU0868494617.USD","IE00BLSP4239.USD","LU2129689514.USD","IE00B1BXHZ80.USD","LU1804176565.USD","LU1366192091.USD","LU0256863811.USD","UYG","LU1201861165.SGD","LU1718418525.SGD","LU2133065610.SGD","LU0683600562.USD","XLF","LU0070302665.USD","LU1883839398.USD","IE00BLSP4452.SGD","LU0149725797.USD","LU1069347547.HKD","LU2596442595.SGD","IE00B19Z3581.USD","TFNS","IE0001KFT4U8.USD","LU0256863902.USD","LU0310800965.SGD","LU1496350171.SGD","BK4504","BK4585","IE00BZ1G4Q59.USD","LU0128525689.USD","VFH","LU0971096721.USD","BK4588","LU0203345920.USD","LU0306807586.USD","LU0980610538.SGD","LU1791807156.HKD","IE0002270589.USD","LU0417517546.SGD","LU0053666078.USD","LU0130103400.USD","IYG","FNCL","LU0320765489.SGD","LU1267930227.SGD","LU0306806265.USD","LU0321505868.SGD","XLV","IE00BBT3K403.USD","LU0234572021.USD","LU1506573853.SGD","LU0130102774.USD","BK4534","BK4207","LU0052756011.USD","LU0477156797.USD","BK4559","BK4581","IE00B19Z3B42.SGD","BK4553","LU0640476718.USD","LU0208291251.USD","LABU","FTXO","LU2129689605.HKD","LU1291159041.SGD","BAC","LU0648000940.SGD","LU1989771016.USD","LU1162221912.USD","LU0203347892.USD","LU1880398554.USD","LU0477156953.USD","LU0321505439.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669466380","title":"实施强省会战略系列报道丨锚定万亿目标 主导产业加快聚势跃升","url":"https://stock-news.laohu8.com/highlight/detail?id=2669466380","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669466380?lang=zh_cn&edition=fundamental","pubTime":"2026-09-24 17:00","pubTimestamp":1790240400,"startTime":"0","endTime":"0","summary":"锚定万亿目标 主导产业加快聚势跃升——实施强省会战略系列报道之一石家庄强化龙头企业引领带动，聚力培育壮大生物医药、新一代电子信息等5个千亿级产业集群。两大战略性新兴产业增速领跑，成为拉动全市产业升级的核心引擎。2026年，石家庄市将实施重点建设项目367个，总投资3791.7亿元，年度预计投资576.1亿元。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/wm/2026-09-24/doc-inisxnvc0358330.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["XBI","BK4585","BK4588","BK4581"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":200,"code":"91000000","status":"200"}]}}